aripiprazole
aripiprazole is listed in the FDA National Drug Code directory with 50 NDC codes, marketed under brand names including aripiprazole, ARIPIPRAZOLE, ABILIFY MAINTENA. Available dosage forms: tablet, injection, powder, lyophilized, for suspension, extended release, kit, solution.
Drug Details
- Generic Name
- aripiprazole
- Brand Names
- aripiprazole, ARIPIPRAZOLE, ABILIFY MAINTENA
- Application Number
- ANDA201519
- Sponsor
- Torrent Pharmaceuticals Limited
- NDC Codes
- 50
- Dosage Forms
- TABLET, INJECTION, POWDER, LYOPHILIZED, FOR SUSPENSION, EXTENDED RELEASE, KIT, SOLUTION
- Routes
- ORAL
- Active Ingredients
- ARIPIPRAZOLE
Indications and Usage
1 INDICATIONS & USAGE Aripiprazole tablets are indicated for the treatment of: Schizophrenia Acute Treatment of Manic and Mixed Episodes associated with Bipolar I Disorder Adjunctive Treatment of Major Depressive Disorder Irritability Associated with Autistic Disorder Treatment of Tourette’s Disorder Aripiprazole tablets are an atypical antipsychotic. Aripiprazole tablets are indicated for: Schizophrenia ( 14.1 ) Acute Treatment of Manic and Mixed Episodes associated with Bipolar I Disorder ( 14.2 ) Adjunctive Treatment of Major Depressive Disorder ( 14.3 ) Irritability Associated with Autistic Disorder ( 14.4 ) Treatment of Tourette’s Disorder ( 14.5 )